Research Article
Effect of Dietary Patterns and Nutrients on Symptoms of Polycystic Ovary Syndrome
Ramesh B1*, Imthiaz FRAR2, Thamilovia SA3, Janani GV4 and Jain AM2
1Department of Behavioral Health and Nutrition, University of Delaware, DE 19711, United States
2Department of Clinical Nutrition, Sri Ramachandra Institute of Higher Education and Research, TN 600116, India
3Department of Food Processing Technology, PSG College of Arts and Science, Civil Aerodome Post, Coimbatore, TN 641014, India
4Department of Food Science and Technology, Pondicherry University, Puducherry 605014, India
2Department of Clinical Nutrition, Sri Ramachandra Institute of Higher Education and Research, TN 600116, India
3Department of Food Processing Technology, PSG College of Arts and Science, Civil Aerodome Post, Coimbatore, TN 641014, India
4Department of Food Science and Technology, Pondicherry University, Puducherry 605014, India
*Corresponding author:Bharathi Ramesh, Department of Behavioral Health and Nutrition, University of Delaware, DE 19711, USA. Email Id: bharathi@udel.edu
Article Information:Submission: 05/07/2024; Accepted: 08/08/2024; Published: 14/08/2024
Copyright: ©2024 Ramesh B, et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Polycystic Ovary Syndrome (PCOS) is now a commonly occurring endocrine-metabolic condition. Symptoms of PCOS include hyperandrogenism, hirsutism, and menstrual irregularities. Dietary intake is a modifiable risk factor and can be modified to prevent or manage PCOS. In this review, we aimed to summarize the current evidence for various dietary patterns and nutrients that have been studied in association with PCOS or the symptoms of PCOS.
In addition, we have also summarized the existing evidence on probiotics in relation to PCOS. The dietary patters of interest are low-carbohydrate diet, Mediterranean diet and intermittent fasting. The nutrients of interest are inositol, selenium, vitamin D and omega-3 fatty acids. Extensive literature review was conducted through PubMed/MEDLINE, Scopus, and Web of Science. Our review identified that dietary patterns including low-carbohydrate diets, the
Mediterranean diet, and intermittent fasting, nutrients like inositol, vitamin D, probiotics, omega-3 fatty acids, and selenium, and probiotics seem to offer benefits for PCOS symptoms such as hormone level improvement, better glycemic control, enhanced insulin sensitivity, improved lipid levels, and reduced inflammation. Therefore, it has been shown that in addition to pharmacotherapy, dietary modifications and supplements can be effective adjunct therapy for PCOS
Keywords:Polycystic Ovary Syndrome (Pcos); Endocrine Disorders; Dietary Patterns; Nutrients
Introduction
Polycystic ovary syndrome (PCOS) is a complex but common
endocrine-metabolic condition that affects 6 to 20% of women
of reproductive age, depending on the criteria used for diagnosis
[1] .It is an oligogenic disorder in which a variety of genomic and
environmental variables interplay to determine the diverse clinical,
and biochemical phenotype of the disorder [2] .The pathogenesis
of this condition is not completely known but is considered
multifactorial, which includes genetic, transgenerational, and
environmental components, comprising diet and other lifestyle issues.
These factors drive the abnormalities involved in the pathophysiology
of PCOS, primarily defects in the hypothalamic–pituitary-axis,
ovarian function, and insulin secretion/action which in turn affects
steroidogenesis, ovarian follicle development, and metabolism
[3,4]. PCOS cannot be diagnosed with a single test; rather, the
condition is determined by the presence of three distinct factors:
oligo-anovulation, androgen excess, and ultrasound evaluation
of polycystic ovarian morphologywhich can clinically manifest as
irregular menses, hirsutism, acne, and metabolic dysfunction [3,5].
As a result of metabolic dysfunction, women with PCOS are prone
to insulin resistance coupled with compensatory hyperinsulinemia
which puts them at high risk for developing obesity, Type 2 diabetes
mellitus (T2DM), cardiovascular disease, and gynecological cancer
[1,6].
In order to improve a variety of health outcomes, lifestyle
modification is one of the suggested treatment techniques for PCOS
in the international evidence-based guidelines [7]. PCOS treatment
should be symptom-focused, long-term, dynamic, and individualized
to the patient’s needs, expectations, and changing circumstances.
The effects of ovarian dysfunction, hyperandrogenism, and/or
related metabolic problems should all be the focus of therapeutic
strategies [8]. Although there is no cure for PCOS, first-line
management involves measures such as dietary changes and exercise
that focus on enhancing insulin sensitivity and preventing longterm
health consequences as an unhealthy diet, along with lowgrade
inflammation, hyperinsulinemia, and hyperandrogenism is
a major contributor to the metabolic risk factors linked to PCOS
pathophysiology [9,10].
Numerous symptoms, including insulin resistance, infertility,
oxidative stress, hirsutism, and elevated inflammatory markers, are
experienced by women with PCOS. PCOS causes infertility, which has
an overall prevalence of 5% to 15% [11]. Ovarian cyst development
involves a variety of negative side effects, including issues with the
menstrual cycle (heavy/irregular periods/spotting) [12]. Long and
irregular menstrual cycles associated with PCOS have been linked to
greater levels of androgen and lower levels of Sex-Hormone Binding
Globulin (SHBG), resulting in hormonal imbalance that eventually
leads to infertility [13]. One of the signs of PCOS hyperandrogenism is
hirsutism, which is the presence of facial terminal hair that resembles
masculine facial hair. 60–80% of women with PCOS have hirsutism
[14,15]. This varies between ethnic groups and is influenced by
androgens (particularly, testosterone), which also affects the extent to
which hair grows. Because androgen has a large influence on PCOS,
folliculogenesis is diminished as a result. A rise in the number of tiny
antral follicles is caused by early-stage increases in androgens, which
also cause the production of primordial follicles [16].
Obesity is the primary cause of numerous metabolic disorders
in our body and interacts positively with PCOS [17]. According to
recent research, normal-weight women are at risk and can easily shift
from being healthy to being ill, regardless of body weight, if the fat
is deposited in the visceral area of the body [18]. This is true even
though body weight is linked to PCOS issues. Regardless of Body
Mass Index (BMI), visceral fat is common in thin women with
PCOS [19]. Visceral adiposity and obesity cause inflammation and
insulin resistance(IR), which in turn cause metabolic abnormalities
in women’s bodies in those who have PCOS [20]. Hyperinsulinemia,
hyperandrogenism, IR, and greater androgen levels are all positively
correlated in women with PCOS [21,22]. Acne is a significant and
typical symptom of PCOS and is brought on by the inflammation of
the pilosebaceous glands. Dihydrotestosterone, a powerful type of
testosterone, is produced in greater amounts, which increases sebum
production and disturbs follicular epithelial cells.
Nutritional interventions play a crucial role in managing and
preventing complications associated with PCOS. A diet rich in whole
foods, lean proteins, healthy fats, and low in refined sugars and
processed foods, can help regulate insulin levels, reduce inflammation,
and promote hormonal balance. These dietary adjustments can
mitigate common PCOS symptoms such as weight gain, irregular
menstrual cycles, and IR, thereby reducing the risk of developing more
severe complications like type 2 diabetes, cardiovascular diseases, and
infertility. By adopting a tailored nutritional plan, individuals with
PCOS can significantly improve their overall health and quality of
life. This review examines current knowledge of the nutritional
components of PCOS and proposes strategies for managing food
and nutritional therapy in PCOS patients. This review lays out some
broad guidelines around which a customized plan for every patient
can be created.
Methods
To ensure a thorough review of the existing research on PCOS
symptoms and dietary interventions, the literature search for this
article was conducted using multiple databases such as PubMed/
MEDLINE, Scopus, and Web of Science. A combination of keywords
and Medical Subject Headings (MeSH) words such as “polycystic
ovary syndrome”, “PCOS”, “dietary interventions”, “intermittent
fasting”, “low-carbohydrate diet”, “ketogenic diet”, “Mediterranean
diet”, “vitamin D”, “inositol”, “selenium”, “omega-3”, “probiotics”
and related terms were used. Boolean operator “AND” was utilized
to refine the search and obtain the most relevant studies. In addition,
studies cited in the articles referenced in this paper were reviewed
to identify relevant articles that might have been missed and ensure
a comprehensive and thorough review of the topic. Peer-reviewed
original research, systematic review articles and meta-analyses
were included in this paper. Multiple researchers were involved in
performing the literature review to screen and identify the relevant
articles.
This study does not require Institutional Review Board approval
as there were no human subjects involved. This review summarizes
the results of existing research done on this topic.
Results
Low-carbohydrate diet:
Low-carbohydrate diets (LCDs) are of many types, with the
difference being the amount of carbohydrates (CHO) consumed and
whether protein and fats are restricted or increased. LCDs typically
allow 10-25% of total daily energy (TDE) to be obtained from CHO,
10-30% from protein, and 25-45% from fats. A popular form of LCDs
called the ketogenic diet (KD) is a type of low-carb high-fat diet
where CHO are severely restricted to <10% of TDE, protein to about
10% of TDE, and fats to an increased quantity of 70-80% of TDE.
KD restricts protein to 10% of TDE to prevent gluconeogenesis and
can also be hypocaloric to promote weight loss[23]. Another popular
form of LCD is the Atkins diet which restricts CHO to 20-100g/day
but does not restrict protein and fats[24]. Despite the LCDs and
specifically KD being highly restrictive, they have been rapidly gaining
popularity due to their association with improved glycemic control,
improvement in hyperlipidemia, increased weight loss, and especially
reduction in abdominal obesity. In addition to that, LCDs increase
satiety and lead to the consumption of fewer calories naturally.
Healthy fats such as omega-3 fatty acids (found in fish, flaxseeds, and
walnuts) have anti-inflammatory properties that can help reduce the
inflammation associated with PCOS.Monounsaturated fats (found
in olive oil, avocados, and nuts) can improve lipid profiles and
reduce cardiovascular risks, which are higher in women with PCOS.
Fats promote satiety and help maintain a stable blood sugar level,
reducing cravings and overeating, which is beneficial for managing
PCOS symptoms.They also provide essential fatty acids necessary for
hormone production and regulation.Adequate protein intake helps maintain muscle mass, which is
crucial for a higher metabolic rate. This helps in managing weight and
improving overall metabolic health in women with PCOS.Proteins aid
in the repair and growth of tissues, which can be beneficial for women
experiencing hair loss and other tissue-related symptoms of PCOS.
Proteins have a lower glycemic index and help in stabilizing blood
sugar levels, reducing insulin spikes and improving insulin sensitivity.
Improved insulin sensitivity helps in reducing the hyperinsulinemia
and hyperandrogenism commonly seen in PCOS. It is due to this
reason that KD, which was originally developed for the management
of epilepsy, gained popularity for weight loss[23]. LCDs have been
hypothesized to be helpful in the management of symptoms of PCOS
such as hyperinsulinemia, IR, hyperlipidemia, and acne.
Studies have reported that LCDs can lower blood glucose, insulin,
and hemoglobin A1c (HbA1c) levels and increase insulin sensitivity.
They can also improve hyperlipidemia by reducing elevated LDL and
triglyceride levels. High-glycemic foods and a high-glycemic-load
diet can play a role in the development of acne through their effect
on insulin, androgen hormones, and insulin-like growth factor-1
(IGF-1) activity [25]. It has been shown that replacing CHO with fat,
preferably mono and polyunsaturated fats, can have beneficial effects
on insulin levels in PCOS [26]. Restricting CHO can therefore reduce
the spike in insulin and IGF-1 levels and reduce the development
of acne mediated by androgen hormones. There are limited studies
evaluating the effects of LCDs in women with PCOS. In the studies
that exist, the sample size is often small.
However, these studies show that LCDs, specifically KD, have a
positive effect on anthropometric measurements and biochemical
parameters such as free testosterone, luteinizing hormone levels
(LH), Follicle stimulating hormone (FSH) levels, LH/FSH ratio
(LH and LH/FSH ratio are elevated in women with PCOS), blood
glucose, insulin level, etc. In a study by Paoli et al. [27] women who
were fed a ketogenic Mediterranean diet for 12 weeks observed a
reduction in body weight with a mean reduction of 9.4 kgand a
reduction in glucose and insulin levels, free testosterone, LH, LH/
FSH ratio, triglycerides, and cholesterol. In another study, women
who consumed <20g of CHO/day for 24 weeks observed a mean
weight loss of 12%, a 22% reduction in free testosterone, and a 36%
reduction in LH/FSH [28]. A study by Cincione et al. showed that
KD improved insulin sensitivity in obese women with PCOS and also
lowered LH levels and LH/FSH ratio [29]. In a study by Li et al., apart
from improvement in anthropometric measurements and menstrual
cycle, KD also had a beneficial effect on liver function [30]. Overall,
it can be summarized that KD is associated with an improvement
in anthropometric characteristics, reproductive hormone levels,
glycemic control, insulin sensitivity, blood lipid levels, and liver
function.
Mediterranean diet:
According to Lluis Serra-Majem et al. [31] the Mediterranean diet
is thought to have its roots in the early 1950s and 1960s eating habits
of the civilizations that surrounded the Mediterranean Sea, primarily
Greece and Italy but also includes about 20 other countries that are
dispersed throughout the region. Whole grains, legumes, fruits, and
vegetables are all part of the Mediterranean diet, along with coldpressed
olive oil as the main source of fat. Seafood, meat, and dairy
products are consumed in moderation, while eggs, saturated fats,
and red meat are consumed in smaller amounts. Some foreign foods
have been included in the conventional dietary pattern as a result of
various cultural interactions. Over time, the Mediterranean diet has
evolved and adapted, incorporating various foreign foods into the
traditional dietary pattern. This evolution is largely due to the diverse
cultural interactions and exchanges within the region, bringing in new
ingredients, cooking methods, and culinary influences from different
parts of the world. For example, foods such as quinoa from South
America, avocados from Central America, and spices like turmeric
and curry from Asia have been integrated into the Mediterranean
culinary tradition, enriching and diversifying it while maintaining its
core principles.Ancel Keys, an American scientist who developed the
Seven Countries Study, discovered a positive correlation between the
Mediterranean eating pattern and a low incidence of cardiovascular
diseases when compared to the Northern European Countries
after a 25-year follow up, which led to increased attention to the
Mediterranean diet’s health benefits [32].In the Prevención con DietaMediterránea (PREDIMED)
study, which was conducted over a 4-year period, the effects of a
Mediterranean diet over a 3-month period on circulating inflammatory
biomarkers like Interleukin-6 (IL-6) and C-reactive protein (CRP)
were compared to those of a low-fat diet [33]. It was discovered that
the fasting insulin levels, blood glucose levels, IL-6, and Homeostatic
Model Assessment (HOMA) score decreased in the group that
adhered to a Mediterranean diet that was supplemented with olive
oil and nuts. In another study, the intervention group was advised to
follow a diet that included at least 250–300 g of fruits, 125–150 g of
vegetables, 25–30 g of walnuts per day, and increased consumption
of olive oil over the course of 24 months. The study examined the
effects of a Mediterranean diet on vascular inflammatory markers
and endothelial function. The Mediterranean diet, which contains
50 to 60% CHO, 15 to 20% protein, and less than 30% fat, was also
advised, as was daily exercise for 30 minutes. After following the diet
for two years, it was seen that hs-CRP levels, IL-7 and Interleukin-18
(IL-18), IR, and the HOMA score were decreased. The experimental
group also had a substantial decrease in body weight, BMI, and waist
circumference [34].
Although the precise mechanism by which a Mediterranean diet
produces health benefits is not fully understood, several approaches
have been proposed to play a major role. These include a reduction in
saturated fat intake as the Mediterranean diet involves a lesser intake
of red meat and dairy products, by the quenching of free radicals, by
the antioxidant vitamins and phytochemicals coming from a variety
of whole grains, legumes, nuts, and seeds, weight reduction, and
by impairing the production of free radicals.Although the precise
mechanism by which a Mediterranean diet produces health benefits
is not fully understood, several approaches have been proposed to
play a major role. These include reducing saturated fat intake, as
the diet involves eating less red meat and fewer dairy products. The
diet also provides antioxidant vitamins and phytochemicals from
whole grains, legumes, nuts, and seeds, which help quench free
radicals. Additionally, weight reduction and impaired production of
free radicals are believed to contribute to the health benefits of the
Mediterranean diet.One of the ways the Mediterranean diet may
aid in weight loss is through the production of short-chain fatty
acids by the gut microbiota from a variety of resistant starches and
oligosaccharides consumed on the Mediterranean diet. These short chain
fatty acids aid in promoting a sense of satiety by increasing the
production of hormones like glucagon-like peptide-1 (GLP-1) and
peptide-YY, which inhibit gastric emptying [35].
Intermittent Fasting in PCOS:
Intermittent fasting (IF) is the practice of alternating between
eating and fasting, and it is growing in popularity as a replacement
for continuous calorie restriction due to new research demonstrating
similar benefits for weight loss and cardiometabolic health [36,37].
Time-restricted feeding (TRF), alternate-day fasting (ADF), and the
5:2 diet (eating normally for 5 days and restricting calories to 500-
600 for 2 non-consecutive days)are all included under the broad term
of “intermittent fasting”36. TRF entails limiting the eating window to
a predetermined number of hours per day (often 4 to 10 h) and fasting
with calorie-free liquids for the remaining hours. Participants in ADF
shift between “feast days” where they eat without restriction and “fast
days” where they only consume water or < 25% of their daily energy
needs. The 5:2 diet, on the other hand, is a modified variation of ADF
that allows for five feast days and two fast days each week [38].The majority of clinical research has concentrated on applying
intermittent fasting regimens in the obese population with metabolic
syndrome to reduce weight and improve health by delaying the
progression of cardiovascular disease, hypertension, and T2DM [39].
Through a variety of mechanisms, metabolic switching induced across
these various models of IF increases longevity, reduces body mass,
and enhances metabolism39,40. IF is also found to be advantageous
in lowering IR along with improving leptin and adiponectin levels
[39]. There are limited studies evaluating the effects of IF in women
with PCOS. TRF entails a period of fasting, allowing a decline in
insulin levels with an increase in insulin sensitivity, and concurrent
improvement in glucose control [41]. This is consistent with a study
by Li et al. [42] in which 15 women with PCOS with anovulation
between the ages of 18 and 31 took part in a 6-week trial that was
split into two separate phases of a 1-week baseline weight stabilization
period and a 5-week TRF period. The eight-hour TRF reduced
weight, particularly body fat, and increased SHBG, with decreased
total testosterone and free androgen index (FAI), which improved
menstrual cycle irregularity in 11 out of 15 patients [42].
Similar to this, premenopausal women with obesity participated
in a trial by Harvie et al. and followed a 5:2 diet where they fasted
with 500 kcal two days each week. After a 7% weight loss compared
to baseline, the FAI dramatically decreased after 24 weeks of the
5:2 diet. On the other hand, Dehydroepiandrosterone Sulfate
(DHEA-S), testosterone, and androstenedione did not change
[43]. These studies further established the connection between
hyperandrogenism and metabolic abnormalities by showing that
changes in androgen indicators were associated with decreases in
body weight, inflammation, and IR38. Furthermore, it has been
claimed that a time-restricted eating plan that limits nighttime
food intake enhances postprandial insulin and glucose handling as
it aligns circadian rhythm with diurnal food intake [44]. The study
by Floyd et al.44demonstrated that an early time-restricted feeding
(eTRF) regimen, where participants consumed all their meals in
a 6-hour window ending before 3 p.m., significantly improved
various cardiometabolic health markers. Specifically, eTRF enhanced
postprandial insulin sensitivity, increased beta-cell responsiveness,
and lowered blood pressure. All participants except one experienced
an improvement of at least 5 mU/L in mean postprandial insulin
levels. Overall, these findings, though limited, suggest that fasting can
considerably lower androgen markers in premenopausal women with
PCOS, especially if calories are ingested earlier in the day [38].
Inositol:
Inositol is a sugar alcohol that belongs to a group of natural
polyols called cyclohexanols, containing six carbon units with each
carbon attached to a hydroxyl group. Epimerization of the hydroxyl
groups using specific epimerases or phosphorylation using specific
phosphorylases leads to the formation of 9 different forms of inositol,
including the two main forms - Myo-inositol (MI) and D-chiroinositol
(DCI). MI and DCI are the most common and abundantly
present forms in the human body[45]. Humans can synthesize MI in
the body (up to 4 g/day), mainly in the kidneys, but can also obtain it
through diet (about 1 g/day) from food sources such as citrus fruits,
beans, grains, nuts, and seeds [46]. MI is biosynthesized in the body
through the process of isomerization of glucose-6-phosphate to form
inositol-3-phosphate which is then converted to free MI through
dephosphorylation. Free MI can be converted to DCI through
epimerization of the hydroxyl groups but only a fraction of free MI is
converted to DCI through this process [47]. MI and DCI are present
in the plasma in a 40:1 ratio.MI plays an important role in the uptake of glucose and
transduction of cellular signals including endocrine signals such
as insulin, FSH, and thyroid-stimulating hormone (TSH) while
DCI plays an important role in androgen synthesis in the ovaries
[47]. Inositol has been shown to improve the quality of oocytes and
embryos and increase ovulation frequency and rate of pregnancy [48].
Moreover, deficiency of inositol has been linked to the pathogenesis
of conditions such as diabetes, metabolic syndrome, spina bifida, and
PCOS. MI and DCI have been shown to be helpful in the management
of PCOS, especially in the ratio of 40:1 at a dose of 2 grams twice
a day[49,50]. In a study by Nordio et al.[49, 56] participants aged
18-45 years diagnosed with PCOS were studied. MI and DCI were
administered in different ratios keeping the total MI + DCI dose
at 2 grams twice a day for all groups for three months. The results
showed that there was an improvement in ovulation in the 40:1 group
compared to the other groups and that the other ratios did not have
beneficial effects.
In a study by Bevilacqua et al.[51]using a mice model, an
experimental group of C57BL/6N mice was induced to develop
PCOS and were treated with inositol at a dose of 420 mg/kg body
weight with different ratios of MI: DCI. The group that received a
40:1 ratio showed faster recovery of fertility compared to the control
group and the groups that received MI and DCI at 5:1, 20:1, and 80:1
ratio. Surprisingly, a high dose of DCI such as the 5:1 ratio seemed to
impact fertility negatively. While metformin seems to be the first line
of therapy for IR in women with PCOS, it has been demonstrated that
MI has a similar function and can also improve the impact of insulin
sensitizers such as metformin and clomiphene in those who are trying
to conceive[52]. Thus, it can be established that inositol can play an
important role in improving fertility in women with PCOS and the
optimal dosage of inositol for PCOS is 2 grams twice a day at a ratio of
40:1 (MI: DCI) to improve fertility. Furthermore, inositol can also be
considered an adjunct therapeutic agent for IR and can be combined
with other insulin-sensitizing agents.
Adequate dietary intake of MI has been shown to have significant
effects on various health conditions. MI plays a crucial role in insulin
signaling and glucose metabolism, making it beneficial in managing
insulin resistance and type 2 diabetes [47]. MI has been linked to
improved fertility outcomes in women with PCOS due to its impact
on ovarian function and hormone regulation. Incorporating MI-rich
foods into the diet can support overall metabolic health and specific
conditions such as diabetes and PCOS[49,50]. Consuming a diet rich
in MI, through foods like citrus fruits, beans, grains, nuts, and seeds,
can provide a natural source of this essential nutrient, potentially
enhancing its beneficial effects. The dietary inclusion of MI-rich foods
can complement medical treatments and lifestyle interventions aimed
at managing these conditions, leading to a more holistic approach to
health maintenance and disease prevention.
Probiotics:
Probiotics are defined as “live microorganisms which, when
administered in adequate amounts confer a health benefit on the host
“[53] by the FAO of the UN and the WHO. Bifidobacteria and Lactic
Acid Bacteria (LAB), which include the Lactobacillus, Lactococcus,
Enterococcus, Streptococcus, and Leuconostoc species, are two of the
most popular probiotic strains [54]. Aspergillus niger, Saccharomyces
boulardii, and a few other yeasts and molds also function as probiotics.
Hexose carbohydrates may be turned into lactic acid by LABs, which
results in an environment that is acidic and inhibits the growth of
dangerous microbes54. Although the precise mechanism of probiotic
action is unclear, some significant ways in which probiotics have
been shown to be beneficial include immune system stimulation,
toxin inactivation, competition for adhesion sites, and secretion of
antimicrobial substances[55].It has been demonstrated that the diversity of the gut microbiota
is correlated with IR and hyperandrogenism, which are frequent
symptoms of PCOS [56]. According to the “dysbiosis of gut
microbiota” theory put forth by Tremellen et al.[57], a high sugar
and fat diet-induced imbalance in the gut bacterial flora causes
hyperandrogenism by increasing the gut mucosal permeability, which
allows for the passage of lipopolysaccharide (LPS), an endotoxin
produced as a result of Gram-negative bacteria rupturing. This
generates an immunological response that disrupts the operation
of insulin receptors and causes IR. Both of these crucial PCOS
markers—increased androgen synthesis in ovarian theca cells and
disruption of follicle development—are caused by an elevated amount
of circulating insulin[58]. When compared to healthy women,
women with PCOS have been found to have elevated levels of several
inflammatory mediators, including hs-CRP, a marker of low-grade
chronic inflammation, tumor necrosis factor (TNF), and interleukins
like IL-6, which promotes the production of CRP in the liver[59].
Probiotic supplementation with Lactobacillus acidophilus,
Lactobacillus casei, and Bifidobacterium bifidum (2*109 CFU/g each)
for a period of 12 weeks among 60 women with PCOS who were
diagnosed according to the Rotterdam Criteria showed a significant
increase in SHBG and plasma TAC (Total Antioxidant Capacity)
and a significant decrease in serum TT (Total Testosterone), serum
hs-CRP, and plasma MDA (malondialdehyde) which serves as an
indicator for lipid peroxidation concentrations [60]. In another
study, 60 women with PCOS received supplements containing strains
of Lactobacillus acidophilus, Lactobacillus casei, and Bifidobacterium
bifidum (2*109 CFU/g each) for 12 weeks. The results were analyzed
for changes in Fasting Plasma Glucose (FPG), lipid profile, and
markers of IR. In the experimental group receiving probiotics, there
seemed to be a significant decrease in FPG, serum insulin levels,
HOMA-IR, HOMA-B, and a significant increase in Quantitative
Insulin Sensitivity Check Index (QUICKI) [61]. Along with
cyproterone acetate therapy, the administration of probiotic capsules
containing Lactobacillus acidophilus, Lactobacillus plantarum,
Lactobacillus fermentum, and Lactobacillus gasseri (1*109 CFU each)
to women with PCOS has also demonstrated a significant reduction
in IL-10 levels, an anti-inflammatory cytokine [62].
Selenium:
According to Lu and Holmgren [63], selenium (Se) is an
important micronutrient and trace element that is crucial for redox
processes such as those involving glutathione peroxidase (GPx) and
thioredoxin reductase (TrxRs). By serving as a cofactor for GPx
during cellular metabolism, se helps to reduce oxidation. It also
interacts with other proteins to generate selenoproteins [64]. There
are 25 selenoproteins in humans, and each one performs a specific
role [65]. Selenoprotein P (SELENOP) is a plasma protein that
contains Se that is made in the liver. It has a variety of purposes, but
its main one is to transport Se from the liver to other tissues. It also
plays a significant part in Se metabolism and antioxidant defense. If
SELENOP declines, Se shortage results in certain dysfunctions and
oxidative damage, while IR is caused by an increase in SELENOP [66].
Se is necessary and performs a crucial role in the endocrine system,
particularly in the production of active thyroid hormone through
interaction with iodothyronine deiodinase (an enzyme that converts
T4 to T3) [67]. Se’s ability to imitate the activities of insulin is one
of its key functions [68]. When Se is supplemented, it will improve
lipid profiles and glucose homeostasis by reducing the expression of
P-selectin and cyclooxygenase-2 (COX-2) [69].Se has an impact on the metabolism of fats and CHO, according
to previous studies. In addition, Se can reduce IR by preventing the
production of inflammatory cytokines such IL-1 and TNF-ɑ [70]. Se is
essential for human health and well-being since deficiencies can lead
to infertility in women and problems throughout the reproductive
process in males [71]. As a result, Se supplementation has several
positive benefits on stress, inflammation, and reproduction in
women with PCOS72. Additionally, Se sulfide supplementation
has several benefits for dermatology [73]. In rats with diabetes,
inducing Se deficiency causes a significant rise in plasma glucose
levels[74]. Serum insulin and HOMA-IR values in women with
abdominal obesity dramatically decreased after receiving 200 μg
of Se per day for six weeks [75]. Contrarily, after receiving 200 μg/
day of Se supplementation for three months, diabetic individuals’
FPG levels increased without changing their blood insulin levels
[76]. Furthermore, Se supplementation significantly reduced the
levels of triglycerides and total cholesterol in research done on
male white rabbits in New Zealand[77]. The positive impact of Se
supplementation enhances metabolic profiles and oxidative stress
indicators in women with PCOS [78].
In a different study conducted in women with PCOS,
supplementing with 200 μg/day of Se led to lower levels of serum
insulin, HOMA-IR, HOMA-B, and QUICKI as well as a significant
drop in serum triglycerides and very low-density lipoprotein (VLDL)
without affecting other lipid parameters and FPG79. In a different
trial, Se supplementation with high doses of 1000 μg on day 1 and 500
μg/day for 2–14 days reduced CRP plasma levels in sepsis patients
[80]. Se is regarded as a non-toxic supplement, however, exceptionally
high doses of Se supplementation, which is an uncommon condition,
can cause unpleasant symptoms including nausea, joint discomfort,
hair loss, weariness, diarrhea, and/or brittlenesss [81]. In a different
study, 3200 g/day of Se supplementation caused participants to exhibit
symptoms of Se toxicity [82]. Se can be consumed in moderation at
400 mcg per day, according to the Institute of Medicine’s reference
consumption [83]. Patients with certain comorbidities, such as
gastrointestinal dysfunction and renal failure, which result in diarrhea
and vomiting, must take the appropriate precautions before receiving
Se supplementation [81].
Vitamin D:
Vitamin D is categorized as a secosteroid structurally because one
of its four rings is broken [84]. It comes in two forms: cholecalciferol
(vitamin D3) and plant-derived ergocalciferol (vitamin D2). The
skin’s sebaceous gland produces the steroid 7-dehydrocholesterol,
which is transformed to cholecalciferol by exposure to sunshine and
ultraviolet B radiation. Exogenous sources of cholecalciferol include
egg yolk and fatty fish. The liver and kidneys convert vitamin D2 and
vitamin D3 to calcitriol, which is the active form of vitamin D. The
25-hydroxylase enzyme in the liver first hydroxylates vitamin D3 to
create 25-OH D, also known as 25-OH cholecalciferol. The active
form, 1,25(OH)2 D, also known as 1,25 dihydroxycholecalciferol or
calcitriol, is produced by the second hydroxylation of 25-OH D in
the kidneys. Two primary mechanisms—genomic action and nongenomic
action—allow calcitriol to carry out its function. Although
vitamin D receptors (VDR) play a major role in the genomic action of
calcitriol, this hormone also exerts rapid cellular action through nongenomic
paths [85]. Although it was previously believed that vitamin
D’s activity was restricted to skeletal development, the widespread
distribution of vitamin D receptors (VDR) in the body now supports
the notion that it performs diverse functions in the body [86].According to studies, between 67 and 85% of women with PCOS
have low levels of vitamin D, which is associated with the severity of
the symptoms. Reproductive, metabolic, and mental health functions
are all impacted by vitamin D status. Vitamin D deficiency is believed
to make PCOS symptoms including hyperandrogenism, IR, and
menstrual irregularities worse [87]. A typical feature of PCOS is
IR, which is primarily seen in women with higher BMIs, showing a
synergistic influence of both PCOS and obesity on hyperinsulinemia.
The association, according to Bikle [86], is brought about by the
pancreas cells’ expression of the VDR and the promotion of insulin
production by vitamin D. By promoting the development of insulin
receptors and activating PPAR-δ (peroxisome proliferator-activated
receptor delta), vitamin D may also increase insulin sensitivity [88].
A member of the nuclear receptor superfamily, PPAR-δ controls
cellular metabolic processes such as insulin production, sensitivity,
and absorption, transport, and beta-oxidation [89].
As hyperinsulinemia in PCOS prevents the liver from producing
SHBG, freer androgen is circulated in the body88. Insulin and LH
work together synergistically to increase androgen production by
theca cells and decrease liver synthesis of the major binding protein
for testosterone, SHBG, causing testosterone to circulate in the
unbound, active form. According to Morgante et al. [90], obese
PCOS patients had lower 25 OH-D concentrations, which are linked
with higher HOMA-IR, BMI, triglycerides, and total testosterone
levels. According to a comprehensive review and meta-analysis of
randomized controlled trials by Lagowska et al. [91], the type, dosage,
and frequency of vitamin D had a substantial impact on the HOMAIR
score. When combined with micronutrients including calcium,
magnesium, zinc, and vitamin K, a lower dose of vitamin D (]4000
IU/day) had a favorable effect compared to a greater dosage (50,000
IU) given once a week. Jamailian et al. [92] reported a similar finding
regarding the impact of vitamin D (calciferol) when administered in
two dosages of 4000 IU and 1000 IU over the course of 12 weeks to
90 PCOS patients taking metformin. The group receiving 4000 IU
of vitamin D daily in addition to metformin exhibited a significant
improvement in SHBG and TAC, as well as a substantial decrease in
FPG, serum insulin, HOMA-IR, hirsutism, and increase in SHBG. The
HOMA-IR and other indicators were unaffected by the placebo group
with metformin. Ovulation and menstrual regularity improved in
women taking metformin when vitamin D and calcium supplements
were combined [93]. It is well-established that supplementing with a
lower daily vitamin D intake helps with hyperandrogenism, IR, BMI,
menstrual irregularities, and infertility in women with PCOS.
Omega-3 fatty acids:
A class of fatty acids known as omega-3 fatty acids have double
bonds forming between the third and fourth omega carbon atoms.
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are
two of the main dietary sources of long-chain omega-3 fatty acids
for humans, and they can be found in fish and algae. Additionally,
ALA, which is typically found in plant sources, can be converted to
EPA and DHA in the body. The conversion is often 10–14% lower
than what is needed [94]. Omega-3 fatty acids like EPA and DHA,
which are widely known for improving insulin and lipid metabolism
in inflammation and obesity and preventing adiposity, dyslipidemia,
IR, and cardiovascular disease [95], have been demonstrated to be
effective at performing these functions. Yang et.al. [96] conducted
a meta-analysis of nine randomized controlled trials that showed
that women with PCOS who were supplemented with a dosage of
900–4000 mg for a period of 6–24 weeks (mostly 12 weeks) found
a significant improvement in IR, the HOMA index, and a reduction
in inflammation. But a meta-analysis of 3 randomized controlled
trials with doses ranging from 1.2 g to 3.6 g of omega-3 fatty acid
supplements for a duration of 6–8 weeks found no significant
improvement in IR or HOMA-IR [97].Studies have shown that omega-3 fatty acid supplementation
affects testosterone levels and gonad function. According to a
systematic review of clinical trials and cohorts, supplementing
with omega-3 for 12 weeks at doses of 800 mg and 1500 mg for 24
weeks significantly decreased serum levels of total testosterone, free
testosterone (the active form of testosterone), androgen, LH, and
hirsutism score in women with PCOS [98]. Another double-blind
randomized clinical trial on 78 women with PCOS receiving a dosage
of 3g for 8 weeks as opposed to a placebo showed a similar finding
[99]. The results showed both a significant improvement in menstrual
regularity and a decline in testosterone levels. However, neither the
FAI nor the SHBG showed any appreciable variations. In a similar
trial, women with PCOS who took 2 g of omega-3 fatty acids each day
for six months saw a significant increase in monthly regularity and a
decrease in waist circumference [100]. Although studies have shown
that omega-3 fatty acid supplementation can be used in conjunction
with PCOS treatment to reduce IR, elevated TC, and TG, the longterm
efficacy of omega-3 is unknown due to the short study duration
and small sample sizes.
Conclusion
PCOS is a complex endocrine disorder affecting women of
reproductive age and can result in infertility. There are several
symptoms of PCOS including elevated androgen levels, mainly
testosterone, acne, excessive hair growth on body, and insulin
resistance. This review summarizes the current evidence regarding
the association of these dietary patterns and nutrients and symptoms
of PCOS and provides interpretation for clinical practice for dietitians
including the appropriate dosage for supplementation. Based on the
existing research on this topic, it can be summarized that dietary
patterns such as low-carbohydrate diets, Mediterranean diet, and
intermittent fasting appear to have positive effect on the symptoms
of PCOS such as improvement in hormone levels, improved glycemic
control, improved insulin sensitivity, improved blood lipid levels,
decreased wait circumference and reduction in inflammation. In
addition, inositol, vitamin D, probiotics, omega-3 fatty acids, and
selenium which have also been studied in relation to PCOS, are
shown to have positive health benefits such as improvement in
hormone levels, improved fertility and menstruation regularity,
improved blood glucose and serum insulin levels. There are some
limitations to this study. The review primarily focuses on specific
dietary interventions such as low-carbohydrate diets, intermittent
fasting, and certain nutrients like inositol and omega-3 fatty acids.
It does not comprehensively cover all possible dietary patterns or
nutrients that might affect PCOS.This is an emerging area of research
and therefore, limited studies are available on this topic. Long-term
studies are necessary to understand the sustained effects of these
dietary patterns and nutrients on PCOS symptoms.
Funding Source:
This research did not receive any specific grant from funding
agencies in the public, commercial or not-for-profit sectors.Conflict of Interest:
The authors declare that there was no conflict of interest from
preparation to publication of this manuscript.Authors’ Contributions:
BR, FRARI, TSA, JG, AMJ- wrote paper; BR - had primary
responsibility for final content.